CXSS2400091 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(2.2) | New Drug Application | 2024-08-30 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液(CHO细胞) | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2500031 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(1) | Supplementary Application | 2025-01-27 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2200266 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSL2500268 | SSGJ-707注射液 | SSGJ-707 | Injection | Biological Products(1) | New Drug Application | 2025-04-07 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2400177 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液(CHO细胞) | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2400328 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-12-20 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2200214 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXHL2500178 | HIF-117胶囊 | HIF-117 | Capsule | Chemical Drugs(1) | New Drug Application | 2025-02-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSB2300100 | 重组红细胞生成刺激蛋白注射液(CHO细胞) | | Injection | Biological Products(原9) | Supplementary Application | 2023-09-19 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2200218 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2500032 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(1) | Supplementary Application | 2025-01-27 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2200216 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSL2500247 | 注射用SSGJ-705 | SSGJ-705 | Lyophilized | Biological Products(1) | New Drug Application | 2025-03-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2400176 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSL2400705 | 重组红细胞生成刺激蛋白注射液(CHO细胞) | | Injection | Biological Products(1) | New Drug Application | 2024-10-17 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXSL2200509 | 人源化神经生长因子抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2022-10-11 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CXHL2500179 | HIF-117胶囊 | HIF-117 | Capsule | Chemical Drugs(1) | New Drug Application | 2025-02-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
CYSB2300022 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products | Supplementary Application | 2023-01-30 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |